Prolonged immunostimulatory effect of low-dose polyethylene glycol interleukin 2 in patients with human immunodeficiency virus type 1 infection.
about
Zanvil Alexander Cohn 1926-1993Pegylated alpha interferon is an effective treatment for virulent venezuelan equine encephalitis virus and has profound effects on the host immune response to infectionEvaluation of new vaccines in the mouse and guinea pig model of tuberculosisAn artificial antigen-presenting cell with paracrine delivery of IL-2 impacts the magnitude and direction of the T cell response.Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapyClonal T cell expansion induced by interleukin 2 therapy in blood and tumors.Effects of subcutaneous interleukin-2 therapy on CD4 subsets and in vitro cytokine production in HIV+ subjectsConstruction, replication, and immunogenic properties of a simian immunodeficiency virus expressing interleukin-2.Effects of subcutaneous interleukin-2 therapy on phenotype and function of peripheral blood mononuclear cells in human immunodeficiency virus infected patients.Treatment of idiopathic CD4 T lymphocytopenia with IL-2.Cytokines and chemokines in HIV infection: implications for therapy.Tolerogenic activity of polyethylene glycol-conjugated lysozyme distinct from that of the native counterpart.Induction of HIV-1-specific T cell responses by administration of cytokines in late-stage patients receiving highly active anti-retroviral therapyHyaluronan conjugation of antigenic protein to modify immunogenic information
P2860
Q24680249-6B259534-DF87-4113-AC38-1026222C4074Q27469593-F69C7A94-53EC-4002-9629-FADEA39B3E01Q33755534-7E878B0A-512B-464C-AAFA-A1F2EB77A9EAQ35266959-680D6643-1252-416B-82C1-BDB859B044C4Q36696647-E56466AB-7327-494C-9286-209FB4C7F502Q39761568-68698CEE-607B-4D62-A8ED-7B757621F2F0Q39794747-354BFF6F-EB3C-482A-8827-DA3690B5279EQ39878686-6F577D71-72D9-446E-A655-1B21BE01BB6FQ44571925-FF7AFF87-A655-43D4-90BA-B7FDB1EB9F6DQ44593595-60D73051-63E7-4D1F-BC19-7408FE9D0EF9Q47912506-0A3036C9-9C5F-4012-8869-FF97DAF209CEQ48003970-BFA2F2E1-90EA-4C23-BCEE-6CD5362B2C57Q57384728-2B0DA686-9198-46DC-BB2D-264E75D111C8Q57744087-E8CA1D4E-33C4-4B4A-9F79-D7C9BAF4E5BB
P2860
Prolonged immunostimulatory effect of low-dose polyethylene glycol interleukin 2 in patients with human immunodeficiency virus type 1 infection.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Prolonged immunostimulatory ef ...... ciency virus type 1 infection.
@ast
Prolonged immunostimulatory ef ...... ciency virus type 1 infection.
@en
type
label
Prolonged immunostimulatory ef ...... ciency virus type 1 infection.
@ast
Prolonged immunostimulatory ef ...... ciency virus type 1 infection.
@en
prefLabel
Prolonged immunostimulatory ef ...... ciency virus type 1 infection.
@ast
Prolonged immunostimulatory ef ...... ciency virus type 1 infection.
@en
P2093
P2860
P356
P1476
Prolonged immunostimulatory ef ...... ciency virus type 1 infection.
@en
P2093
P2860
P304
P356
10.1084/JEM.177.2.483
P407
P577
1993-02-01T00:00:00Z